Caffeine Enhances Astroglia and Microglia Reactivity Induced by 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) in Mouse Brain
- 31 October 2009
- journal article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 17 (4) , 435-439
Abstract
Several reports suggest that 3,4-methylenedioxymethamphetamine (MDMA) induces neurotoxic effects and gliosis. Since recreational use of MDMA is often associated with caffeinated beverages, we investigated whether caffeine interferes with MDMA-induced astroglia and microglia activation, thus facilitating its neurotoxicity. MDMA (4 × 20 mg/kg) was acutely administered to mice alone or in combination with caffeine (10 mg/kg). CD11b and GFAP immunoreactivity were evaluated as markers of microglia and astroglia activation in the substantia nigra pars-compacta (SNc) and striatum. MDMA was associated with significantly higher CD11b and GFAP immunoreactivity in striatum, whereas only CD11b was significantly higher than vehicle in SNc. Caffeine potentiated the increase in CD11b and GFAP in the striatum but not in the SNc of MDMA-treated mice. The abuse of MDMA is a growing worldwide problem; the results of this study suggest that combination of MDMA plus caffeine by increasing glial activation might have harmful health consequences.Keywords
This publication has 12 references indexed in Scilit:
- Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotectionBritish Journal of Pharmacology, 2009
- Neuro-immune crosstalk in CNS diseasesNeuroscience, 2008
- Interactions between 3,4-methylenedioxymethamphetamine, methamphetamine, ketamine, and caffeine in human intestinal Caco-2 cells and in oral administration to ratsForensic Science International, 2007
- Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA (“Ecstasy”) and MDA (“Love”)Neuropharmacology, 2006
- Microglial activation is a pharmacologically specific marker for the neurotoxic amphetaminesNeuroscience Letters, 2004
- The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)Pharmacological Reviews, 2003
- Neurochemical findings in the MPTP model of Parkinson's diseaseJournal of Neural Transmission, 2001
- Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptorsNeurochemistry International, 2001
- Cytokines in inflammatory brain lesions: helpful and harmfulTrends in Neurosciences, 1996
- Effects of adenosine and two stable adenosine analogues on blood pressure, heart rate and colonic temperature in the ratActa Physiologica Scandinavica, 1986